HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
MRNA
Moderna Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $18.42B
Market Cap
$18.42B
Enterprise Val
$13.88B
P/E Ratio
-6.53
P/B Ratio
2.13
Trailing PEG (1Y)
0.24
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$8.65B
Gross Margin33.33%
Profit Margin33.33%
Return on Equity-30.15%
Return on Assets-22.95%
Current Ratio3.29
Debt/Equity0.15
LT Debt/Equity0.15
Revenue Per Share1.74

Income Statement

Dec 31, 2025
Revenue$678.0M
Cost of Revenue$452.0M
Gross Profit$226.0M
R&D$775.0M
SG&A$308.0M
Operating Expenses$1.08B
Operating Income-$857.0M
Interest Expense$0.00
Tax Expense$27.0M
Net Income-$826.0M
EPS (Basic)$-2.11
EPS (Diluted)$-2.11
EBIT-$799.0M
EBITDA-$732.0M
Consolidated Income-$826.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$2.60B
Accounts Receivable$184.0M
Inventory$153.0M
Current Assets$6.54B
LT Investments$2.34B
Property, Plant & Equipment$2.85B
Intangibles$0.00
Non-Current Assets$5.79B
Total Assets$12.34B
Accounts Payable$317.0M
Current Debt$0.00
Current Liabilities$1.99B
LT Debt$1.26B
Non-Current Liabilities$1.70B
Total Liabilities$3.69B
Total Debt$1.26B
Retained Earnings$7.22B
Shareholder Equity$8.65B
Shares Outstanding390,679,512

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$930.0M
Investing Cash Flow-$48.0M
Financing Cash Flow$581.0M
CapEx-$39.0M
Free Cash Flow$891.0M
Depreciation & Amort.$67.0M
Stock-Based Comp$113.0M
Acquisitions / Disposals$0.00
Investment Activity-$9.0M
Debt Issued/Repaid$588.0M
Equity Issued/Repaid$16.0M
Dividends Paid$0.00
Net Change in Cash$1.46B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h